TITAN PHARMACEUTICALS INC : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Shareholder Director Nominations, Financial Statements and Exhibits (form 8-K)
Item 3.01. Notice of Delisting or Failure To Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On April 5, 2023, Titan Pharmaceuticals, Inc. received a notice from the Listing... | April 11, 2023